Pantoprazole Recall: Camber FD253967 batch 40 mg Rx bottle
Announced 2026-04-29 · FDA
The recall involves Pantoprazole Sodium, Delayed-Release Tablets, 40 mg, 1000-count Rx bottles manufactured for Camber Pharmaceuticals and distributed nationwide in the USA. The recall is for Batch FD253967, Exp 06/26/2027, involving 4,740 bottles, due to discoloration described as darker than normal with lighter spots reported in five complaints.
| Brand | Hetero Labs Limited (Unit V) |
|---|---|
| Product | Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10 |
| Reason | Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots." |
| Severity | moderate |
| Units affected | 4740 |
| Distribution | Nationwide in the USA. |
| Agency | FDA |
| Recall / campaign no. | Batch # FD253967, Exp Date: 06/26/2027 |
WHAT YOU SHOULD DO
- Do not use tablets from Batch FD253967.
- If you have this batch, contact Camber Pharmaceuticals for return or replacement instructions and follow disposal guidance; keep the bottles in their original packaging unless told otherwise.
- If you have consumed any tablets and feel unwell, contact your healthcare provider for advice.
- Consider reporting adverse events to FDA MedWatch.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.